{
    "table_name": "quant_phosphoproteome_AML_ex_vivo_drug_response_primary_cohort_pdc_current",
    "table_fullname": "isb-cgc-bq.CPTAC.quant_phosphoproteome_AML_ex_vivo_drug_response_primary_cohort_pdc_current",
    "column_names": [
        "case_id",
        "sample_id",
        "aliquot_id",
        "aliquot_submitter_id",
        "aliquot_run_metadata_id",
        "study_name",
        "protein_abundance_log2ratio",
        "refseq_id",
        "phosphorylation_sites"
    ],
    "column_types": [
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "FLOAT64",
        "STRING",
        "STRING"
    ],
    "nested_column_names": [
        "case_id",
        "sample_id",
        "aliquot_id",
        "aliquot_submitter_id",
        "aliquot_run_metadata_id",
        "study_name",
        "protein_abundance_log2ratio",
        "refseq_id",
        "phosphorylation_sites"
    ],
    "nested_column_types": [
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "FLOAT64",
        "STRING",
        "STRING"
    ],
    "description": [
        "Unique identifier associated with a specific patient (e.g. 24cb0fcb-63d6-11e8-bcf1-0a2705229b82)",
        "Unique PDC identifier for this sample (e.g. e8d83eb9-693a-11ea-b1fd-0aad30af8a83)",
        "Unique PDC identifier for this aliquot (e.g. e8db124a-693a-11ea-b1fd-0aad30af8a83)",
        "Aliquot submitter id assigned by program (e.g. T14)",
        "Uniquely identifies the aliquot by how it was used in the experiment (based on the labelling reagent and/or biological replicate)",
        "Name of the study (e.g. Pediatric Brain Cancer Pilot Study - Phosphoproteome)",
        "Average log-ratio of sample reporter-ion to common reference of peptide ions associated with the gene in acquisitions from a specific biological sample",
        "Unique identifier given to a sequence in the NCBI RefSeq database",
        "Single letter codes and protein sequence positions of the phosphorylated amino acids (e.g. t304s310, t59)"
    ],
    "sample_rows": [
        {
            "case_id": "1411a35b-1847-4d87-b57f-993dfb9659f8",
            "sample_id": "cb883da7-73ff-40b2-8c82-01c85506d538",
            "aliquot_id": "597258f0-ff16-45a3-854e-45aa2b1d747b",
            "aliquot_submitter_id": "15-00051-1",
            "aliquot_run_metadata_id": "695a16a9-027b-43c8-86c9-f5538b778a6f",
            "study_name": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
            "protein_abundance_log2ratio": -1.8348,
            "refseq_id": "NP_000601.3",
            "phosphorylation_sites": "s706"
        },
        {
            "case_id": "1411a35b-1847-4d87-b57f-993dfb9659f8",
            "sample_id": "cb883da7-73ff-40b2-8c82-01c85506d538",
            "aliquot_id": "597258f0-ff16-45a3-854e-45aa2b1d747b",
            "aliquot_submitter_id": "15-00051-1",
            "aliquot_run_metadata_id": "695a16a9-027b-43c8-86c9-f5538b778a6f",
            "study_name": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
            "protein_abundance_log2ratio": -1.1584,
            "refseq_id": "NP_001005.1",
            "phosphorylation_sites": "s146"
        },
        {
            "case_id": "1411a35b-1847-4d87-b57f-993dfb9659f8",
            "sample_id": "cb883da7-73ff-40b2-8c82-01c85506d538",
            "aliquot_id": "597258f0-ff16-45a3-854e-45aa2b1d747b",
            "aliquot_submitter_id": "15-00051-1",
            "aliquot_run_metadata_id": "695a16a9-027b-43c8-86c9-f5538b778a6f",
            "study_name": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
            "protein_abundance_log2ratio": -1.3186,
            "refseq_id": "NP_001011553.2",
            "phosphorylation_sites": "t227"
        },
        {
            "case_id": "1411a35b-1847-4d87-b57f-993dfb9659f8",
            "sample_id": "cb883da7-73ff-40b2-8c82-01c85506d538",
            "aliquot_id": "597258f0-ff16-45a3-854e-45aa2b1d747b",
            "aliquot_submitter_id": "15-00051-1",
            "aliquot_run_metadata_id": "695a16a9-027b-43c8-86c9-f5538b778a6f",
            "study_name": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
            "protein_abundance_log2ratio": -2.225,
            "refseq_id": "NP_001014972.1",
            "phosphorylation_sites": "s1401"
        },
        {
            "case_id": "1411a35b-1847-4d87-b57f-993dfb9659f8",
            "sample_id": "cb883da7-73ff-40b2-8c82-01c85506d538",
            "aliquot_id": "597258f0-ff16-45a3-854e-45aa2b1d747b",
            "aliquot_submitter_id": "15-00051-1",
            "aliquot_run_metadata_id": "695a16a9-027b-43c8-86c9-f5538b778a6f",
            "study_name": "AML Ex Vivo Drug Response - Primary Cohort - Phosphoproteome",
            "protein_abundance_log2ratio": -2.4866,
            "refseq_id": "NP_001025459.1",
            "phosphorylation_sites": "s351s355"
        }
    ]
}